At Charles River our focus is always on anticipating tomorrow’s drug development needs today and this is why we have invested in the tools, talent and capacity to further the new frontier of cell and gene therapy development. We can support your...
Germfree designs and manufactures complete BioPharma mobile and modular facilities to provide fast and flexible cGMP-compliant production space.
Avenna is a Medtech company developing in-vitro diagnostic platform technology called GlyHealth, which can detect prodromal signals of inflammatory diseases from a small blood sample.
Cartesian Therapeutics is a fully integrated, clinical-stage biopharmaceutical company developing novel cell and gene immunotherapies to treat cancer and autoimmune diseases.
DropGenie is making personalized cellular therapies a reality with a unique automation platform that enables low volume high throughput discovery in precious donor cells.
StemSight is developing off-the-shelf therapies to cure corneal blindness using human induced pluripotent stem cells